Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
George E Fragoulis,1,* Stergios Soulaidopoulos,2,* Petros P Sfikakis,1 Theodoros Dimitroulas,3 George D Kitas4,5 1Rheumatology Unit, Joint Rheumatology Program, Medical School, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, “Laiko&rd...
Enregistré dans:
Auteurs principaux: | Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, Kitas GD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e30d95732ee6484c85c6ccf84dda69b6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Is there a link between inflammation and fatigue in multiple sclerosis?
par: Chalah MA, et autres
Publié: (2018) -
Association of Inflammatory Markers/Cytokines with Cardiovascular Risk Manifestation in Patients with Endometriosis
par: Uzma Rafi, et autres
Publié: (2021) -
Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity
par: Sato S, et autres
Publié: (2020) -
Cooling and Sterile Inflammation in an Oxygen-Glucose-Deprivation/Reperfusion Injury Model in BV-2 Microglia
par: Jana Lücht, et autres
Publié: (2021) -
The Regulation Effect of α7nAChRs and M1AChRs on Inflammation and Immunity in Sepsis
par: Song Hu, et autres
Publié: (2021)